Brad Smith

Brad Smith

policy

President at Microsoft

USA

AI Policy. President at Microsoft.

@BradSmi OpenAlex

30 papers found

International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
International Journal of Radiation Oncology*Biology*Physics20255 citations
DOIOpenAlex
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
The Lancet Oncology20253 citations
DOIOpenAlex
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
The Lancet Oncology20254 citations
DOIOpenAlex
Designing an Electronic Patient Reported Outcomes Information Infrastructure Supported by the RE-AIM Implementation Framework
20251 citations
DOIOpenAlex
Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts
Radiotherapy and Oncology20252 citations
DOIOpenAlex
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
The Lancet20251 citations
DOIOpenAlex
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC).
Journal of Clinical Oncology202441 citations
DOIOpenAlex
MR-guided stereotactic radiation therapy for head and neck cancers
Clinical and Translational Radiation Oncology20243 citations
DOIOpenAlex
Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer
JAMA Network Open202423 citations
DOIOpenAlex
Externally Validated Digital Decision Support Tool for Time-to-Osteoradionecrosis Risk-Stratification Using Right-Censored Multi-Institutional Observational Cohorts
SSRN Electronic Journal20242 citations
DOIOpenAlex
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
The Lancet Oncology20248 citations
DOIOpenAlex
196 Unique Presentation of Mycobacterium haemophilum, Associated with T-cell dysfunction after Nelarabine Administration
Clinical Immunology20241 citations
DOIOpenAlex
Systematic reviews and quality assessment of patient‐reported outcome measures for physical function in comparative effectiveness studies regarding acute postoperative pain after total knee arthroplasty—Do we need to start all over again?
European Journal of Pain20241 citations
DOIOpenAlex
SEX DIFFERENCES IN CARDIAC SARCOIDOSIS TREATMENT AND OUTCOMES: FINDINGS FROM THE CARDIAC SARCOIDOSIS CONSORTIUM
Journal of the American College of Cardiology20241 citations
DOIOpenAlex
Dyadic Yoga for Head and Neck Cancer Patients Undergoing Chemoradiation and their Family Caregivers
Journal of Pain and Symptom Management20246 citations
DOIOpenAlex
Longitudinal changes in the carotid arteries of head and neck cancer patients following radiation therapy: Results from a prospective serial imaging biomarker characterization study
Radiotherapy and Oncology20243 citations
DOIOpenAlex
Clinical acceptability of automatically generated lymph node levels and structures of deglutition and mastication for head and neck radiation therapy
Physics and Imaging in Radiation Oncology20243 citations
DOIOpenAlex
Issue Information
Head & Neck20231 citations
DOIOpenAlex
Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results.
Journal of Clinical Oncology202314 citations
DOIOpenAlex
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study
Clinical and Translational Radiation Oncology202313 citations
DOIOpenAlex
Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
Cancers202318 citations
DOIOpenAlex
Stereotactic Boost and Short-Course Radiotherapy for p16-Associated Oropharynx Cancer (SHORT-OPC): First Planned Interim Safety Analysis from a Randomized Phase II Trial
International Journal of Radiation Oncology*Biology*Physics20232 citations
DOIOpenAlex
Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective study
Oral Oncology Reports20234 citations
DOIOpenAlex
Monitoring Variations in the Use of Automated Contouring Software
Practical Radiation Oncology20234 citations
DOIOpenAlex
Clinical Acceptability of Automatically Generated Lymph Node Levels and Structures of Deglutition and Mastication for Head and Neck Cancer Patient Radiation Treatment Planning
20231 citations
DOIOpenAlex
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study
20231 citations
DOIOpenAlex
Long‐term outcomes of modern multidisciplinary management of sinonasal cancers: The <scp>M. D.</scp> Anderson experience
Head & Neck202311 citations
DOIOpenAlex
Patterns of Failure for Recurrent Head and Neck Squamous Cell Carcinoma Treated with Salvage Surgery and Postoperative IMRT Reirradiation
20234 citations
DOIOpenAlex
857O MACH-EGFR: Individual patient data (IPD) meta-analysis of anti-EGFR monoclonal antibodies (Ab) in patients (pts) with locally advanced (LA) squamous cell carcinomas of head and neck (SCCHN)
Annals of Oncology20234 citations
DOIOpenAlex
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
JAMA Otolaryngology–Head & Neck Surgery202318 citations
DOIOpenAlex